JD

Jennifer R. Downing

FT Forma Therapeutics: 6 patents #44 of 86Top 55%
BO BOE: 3 patents #4,806 of 12,373Top 40%
RT Ribon Therapeutics: 1 patents #6 of 11Top 55%
VH Valo Health: 1 patents #40 of 53Top 80%
Overall (All Time): #437,796 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12398146 Heterobicyclic amides as inhibitors of CD38 Laurie B. Schenkel, Melissa Marie Vasbinder, Kevin Wayne Kuntz, Nicholas Robert Perl 2025-08-26
12378242 Inhibiting CREB binding protein (CBP) Shawn Schiller, Torsten Herbertz, Hongbin Li, Bradford Graves, Steven Mischke +2 more 2025-08-05
12351577 Inhibiting cyclic AMP-responsive element-binding protein (CREB) Shawn Schiller, Torsten Herbertz, Hongbin Li, Bradford Graves, Steven Mischke +2 more 2025-07-08
12162888 Carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Pui Yee Ng, Zhongguo Wang, Tatiana Shelekhin, Justin Andrew Caravella +3 more 2024-12-10
11987584 Heterobicyclic amides as inhibitors of CD38 Laurie B. Schenkel, Melissa Marie Vasbinder, Kevin Wayne Kuntz, Nicholas Robert Perl 2024-05-21
11952377 Quinolines and azaquinolines as inhibitors of CD38 Kevin Wayne Kuntz, Laurie B. Schenkel, Melissa Marie Vasbinder 2024-04-09
11787803 Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors Shawn Schiller, Torsten Herbertz, Hongbin Li, Bradford Graves, Steven Mischke +2 more 2023-10-17
11535621 Heterobicyclic amides as inhibitors of CD38 Laurie B. Schenkel, Melissa Marie Vasbinder, Kevin Wayne Kuntz, Nicholas Robert Perl 2022-12-27
11292791 Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors Shawn Schiller, Torsten Herbertz, Hongbin Li, Bradford Graves, Steven Mischke +2 more 2022-04-05
11254674 Inhibiting CREB binding protein (CBP) Shawn Schiller, Torsten Herbertz, Hongbin Li, Bradford Graves, Steven Mischke +2 more 2022-02-22
10870648 Inhibiting CREB binding protein (CBP) Shawn Schiller, Torsten Herbertz, Hongbin Li, Bradford Graves, Steven Mischke +2 more 2020-12-22